about
Tetanus neurotoxin-mediated cleavage of cellubrevin impairs epithelial cell migration and integrin-dependent cell adhesion.VEGF controls endothelial-cell permeability by promoting the beta-arrestin-dependent endocytosis of VE-cadherinLamellipodium extension and cadherin adhesion: two cell responses to cadherin activation relying on distinct signalling pathwaysA role for a CXCR2/phosphatidylinositol 3-kinase gamma signaling axis in acute and chronic vascular permeability.Semaphorin 3E initiates antiangiogenic signaling through plexin D1 by regulating Arf6 and R-Ras.Targeted killing of cancer cells in vivo and in vitro with EGF-directed carbon nanotube-based drug delivery.Glioblastoma cell-secreted interleukin-8 induces brain endothelial cell permeability via CXCR2Control of CXCR2 activity through its ubiquitination on K327 residue.Negative regulation of NF-κB signaling in T lymphocytes by the ubiquitin-specific protease USP34The guanine exchange factor SWAP70 mediates vGPCR-induced endothelial plasticity.Endothelial secreted factors suppress mitogen deprivation-induced autophagy and apoptosis in glioblastoma stem-like cells.Participation of the E3-ligase TRIM13 in NF-κB p65 activation and NFAT-dependent activation of c-Rel upon T-cell receptor engagement.PARP targeting counteracts gliomagenesis through induction of mitotic catastrophe and aggravation of deficiency in homologous recombination in PTEN-mutant gliomaLuteolin Impacts on the DNA Damage Pathway in Oral Squamous Cell Carcinoma.Complementary roles of intracellular and pericellular collagen degradation pathways in vivo.Desert Hedgehog/Patch2 Axis Contributes to Vascular Permeability and Angiogenesis in Glioblastoma.Regulation of cell-cell junctions by the cytoskeleton.Breaking the VE-cadherin bonds.Emerging roles of Semaphorins in the regulation of epithelial and endothelial junctionsPAKing up to the endothelium.Role of endothelial cell-cell junctions in endothelial permeability.Jumping the barrier: VE-cadherin, VEGF and other angiogenic modifiers in cancer.Critical multiple angiogenic factors secreted by glioblastoma stem-like cells underline the need for combinatorial anti-angiogenic therapeutic strategies.Spitting out the demons: Extracellular vesicles in glioblastoma.A catalytic-independent role for the LUBAC in NF-κB activation upon antigen receptor engagement and in lymphoma cells.Preeclamptic plasma induces transcription modifications involving the AP-1 transcriptional regulator JDP2 in endothelial cells.Remodeling of VE-cadherin junctions by the human herpes virus 8 G-protein coupled receptor.A dileucine motif targets MCAM-l cell adhesion molecule to the basolateral membrane in MDCK cells.A novel function for cadherin-11 in the regulation of motor axon elongation and fasciculation.N-cadherin activation substitutes for the cell contact control in cell cycle arrest and myogenic differentiation: involvement of p120 and beta-catenin.The C-terminus region of β-arrestin1 modulates VE-cadherin expression and endothelial cell permeability.Glioblastoma stem-like cells secrete the pro-angiogenic VEGF-A factor in extracellular vesicles.VE-cadherin and claudin-5: it takes two to tango.β-escin selectively targets the glioblastoma-initiating cell population and reduces cell viability.YGLF motif in the Kaposi sarcoma herpes virus G-protein-coupled receptor adjusts NF-κB activation and paracrine actions.Secreted factors from brain endothelial cells maintain glioblastoma stem-like cell expansion through the mTOR pathway.Interplay between BCL10, MALT1 and IkappaBalpha during T-cell-receptor-mediated NFkappaB activation.Clustering of cellular prion protein induces ERK1/2 and stathmin phosphorylation in GT1-7 neuronal cells.The endoplasmic reticulum acts as a platform for ubiquitylated components of nuclear factor κB signaling.An essential role for Rac1 in endothelial cell function and vascular development.
P50
Q24524084-98C1B519-AAF4-47E5-950F-723B1E3F1C8FQ28116308-E3BF4467-E3D8-4F71-85D5-591C65CF436DQ28511099-BD1A418D-9654-47A2-AFB3-D6C917487F1EQ28566820-09C5800A-67BA-45A1-8BA4-8D190E93096AQ28593676-C5F27B23-B9D6-42F1-9DF7-099A98B438D8Q30486828-896E1EA1-4758-4E6C-B84A-6D2F20DA4813Q31101680-98B9A632-8A82-4833-82C7-442AC9BC9275Q34404577-A4E558DE-F015-40D7-820D-8A3C6243C6DAQ34670791-A82E8F83-BD45-47FE-AD5E-8CB7508FC471Q35108526-15A77295-E704-4FFF-9566-0250F2356B28Q35135190-5F68F936-9270-4379-BA73-1CA106C2E78CQ35218106-E978B856-93CC-48DF-AA7F-88564B80FBAAQ35741555-EB7107DA-F558-4A37-B62A-CE5F0E6543BEQ36042031-19B627D9-011A-4921-AC3D-507D2DDEF8B1Q36177504-EF7F143A-4931-4726-B768-864AE6825F81Q36311161-C6F30192-FCB5-470F-AEA8-306C07AD50DEQ36564376-8B883F4A-A19C-46FF-AFE9-F9235463616DQ37342215-A5E4FB67-4658-400C-80B6-D70A0C1EAF9FQ37427968-FD310F66-0E17-43ED-BAA6-0B81A3D12331Q37589813-B9065272-27DB-40E0-8A04-A317230DF405Q37923371-88C67D0F-B873-45C5-9EFD-96BD32E0B546Q37952877-5138BA7A-B8ED-4A96-B82C-99B747DA784FQ38066416-7AB4819E-DF56-4D2A-8462-0D1F4CCA20C9Q38979589-C1806C68-BB0D-4D61-828F-3D21D8197A2AQ39027104-86815CC3-0674-459A-9951-8AAF37BFA73BQ39080368-36330921-AF45-40DC-A307-B6CCF27FA182Q39659259-4D2F858C-BF00-419A-8698-3D6C1CDFA635Q40271006-8A4862F0-870A-4EA6-99C3-E79536BA6BECQ40441421-999E7F01-7004-4A59-BD5A-A714BB75FC79Q40546042-3BE52620-AAE7-4B7F-BE80-55A3AA8EF86EQ41305453-0DCEBDB0-AF62-4278-B24C-37B3DACDFA3DQ41325366-A0359C6D-FC65-42D0-9607-6100CDFA2CC3Q42015867-C9A62C06-09D6-4861-88C3-CA510977090EQ42183898-DC25F7E1-DE7E-433D-8546-9B3A6D21394DQ42251926-FD0BAEA5-DA19-4475-A259-A218E7B1AFD8Q42728935-6C385106-31CF-4637-9622-4A01A7BD37ABQ43020671-BCE4D159-7A57-45B4-BD95-F7C6A3F6C4CCQ45097930-382E0C58-0991-473F-8CA1-CEFC557715A4Q45220000-D58A826B-1C33-42C6-BED1-10F5CA68FAC7Q46775495-4A2133B9-610C-4AE2-B2B9-791F5345B7BC
P50
description
Forscher
@de
chercheur
@fr
hulumtuese
@sq
investigador
@es
researcher
@en
հետազոտող
@hy
研究者
@zh
name
Julie Gavard
@ast
Julie Gavard
@en
Julie Gavard
@es
Julie Gavard
@nl
type
label
Julie Gavard
@ast
Julie Gavard
@en
Julie Gavard
@es
Julie Gavard
@nl
prefLabel
Julie Gavard
@ast
Julie Gavard
@en
Julie Gavard
@es
Julie Gavard
@nl
P21
P31
P496
0000-0002-7985-9007